| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9759 |
| Human Intestinal Absorption | HIA+ | 0.9804 |
| Caco-2 Permeability | Caco2- | 0.5417 |
| P-glycoprotein Substrate | Non-substrate | 0.7055 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5752 |
| Non-inhibitor | 0.9906 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8505 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4732 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7792 |
| CYP450 2D6 Substrate | Non-substrate | 0.7382 |
| CYP450 3A4 Substrate | Non-substrate | 0.5000 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5541 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6112 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8912 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5527 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5418 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8089 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8733 |
| Non-inhibitor | 0.7680 |
| AMES Toxicity | Non AMES toxic | 0.6895 |
| Carcinogens | Non-carcinogens | 0.7193 |
| Fish Toxicity | Low FHMT | 0.5596 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7471 |
| Honey Bee Toxicity | High HBT | 0.7855 |
| Biodegradation | Not ready biodegradable | 0.9835 |
| Acute Oral Toxicity | II | 0.7258 |
| Carcinogenicity (Three-class) | Non-required | 0.6036 |